BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35888713)

  • 1. Dissecting the Roles of Lipids in Preeclampsia.
    Yang Y; Wang Y; Lv Y; Ding H
    Metabolites; 2022 Jun; 12(7):. PubMed ID: 35888713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors.
    Tomimatsu T; Mimura K; Matsuzaki S; Endo M; Kumasawa K; Kimura T
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular dysfunction in preeclampsia.
    Brennan LJ; Morton JS; Davidge ST
    Microcirculation; 2014 Jan; 21(1):4-14. PubMed ID: 23890192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concentrations of antiangiogenic factors, triglycerides, glucose and insulin in women with two types of preeclampsia].
    Kornacki J; Wirstlein P; Skrzypczak J
    Ginekol Pol; 2013 Sep; 84(9):770-5. PubMed ID: 24191515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of preeclampsia.
    Dekker GA
    Pregnancy Hypertens; 2014 Jul; 4(3):246-7. PubMed ID: 26104648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal Vascular Malperfusion and Adverse Perinatal Outcomes in Low-Risk Nulliparous Women.
    Wright E; Audette MC; Ye XY; Keating S; Hoffman B; Lye SJ; Shah PS; Kingdom JC
    Obstet Gynecol; 2017 Nov; 130(5):1112-1120. PubMed ID: 29016509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Dysregulation of the Prolactin/Vasoinhibin Axis Appears to Contribute to Preeclampsia.
    Lenke L; Martínez de la Escalera G; Clapp C; Bertsch T; Triebel J
    Front Endocrinol (Lausanne); 2019; 10():893. PubMed ID: 31998232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction.
    Tomimatsu T; Mimura K; Endo M; Kumasawa K; Kimura T
    Hypertens Res; 2017 Apr; 40(4):305-310. PubMed ID: 27829661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.
    Shah DA; Khalil RA
    Biochem Pharmacol; 2015 Jun; 95(4):211-26. PubMed ID: 25916268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dyslipidemia in preeclampsia-A review of lipidomic analysis of blood, placenta, syncytiotrophoblast microvesicles and umbilical cord artery from women with preeclampsia.
    Wojcik-Baszko D; Charkiewicz K; Laudanski P
    Prostaglandins Other Lipid Mediat; 2018 Nov; 139():19-23. PubMed ID: 30248406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review.
    Ives CW; Sinkey R; Rajapreyar I; Tita ATN; Oparil S
    J Am Coll Cardiol; 2020 Oct; 76(14):1690-1702. PubMed ID: 33004135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of placental oxidative stress and lipid peroxidation in preeclampsia.
    Gupta S; Agarwal A; Sharma RK
    Obstet Gynecol Surv; 2005 Dec; 60(12):807-16. PubMed ID: 16359563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between hypertensive disorders in pregnancy and placental maternal and fetal vascular circulation.
    Kovo M; Bar J; Schreiber L; Shargorodsky M
    J Am Soc Hypertens; 2017 Nov; 11(11):724-729. PubMed ID: 28967550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of preeclampsia with aspirin.
    Rolnik DL; Nicolaides KH; Poon LC
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1108-S1119. PubMed ID: 32835720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-eclampsia.
    Chappell LC; Cluver CA; Kingdom J; Tong S
    Lancet; 2021 Jul; 398(10297):341-354. PubMed ID: 34051884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procyanidin B2 ameliorates endothelial dysfunction and impaired angiogenesis via the Nrf2/PPARγ/sFlt-1 axis in preeclampsia.
    Liu L; Wang R; Xu R; Chu Y; Gu W
    Pharmacol Res; 2022 Mar; 177():106127. PubMed ID: 35150862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.
    Possomato-Vieira JS; Khalil RA
    Adv Pharmacol; 2016; 77():361-431. PubMed ID: 27451103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia.
    Iriyama T; Sun K; Parchim NF; Li J; Zhao C; Song A; Hart LA; Blackwell SC; Sibai BM; Chan LN; Chan TS; Hicks MJ; Blackburn MR; Kellems RE; Xia Y
    Circulation; 2015 Feb; 131(8):730-41. PubMed ID: 25538227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The maternal blood lipidome is indicative of the pathogenesis of severe preeclampsia.
    He B; Liu Y; Maurya MR; Benny P; Lassiter C; Li H; Subramaniam S; Garmire LX
    J Lipid Res; 2021; 62():100118. PubMed ID: 34547287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.